Go Pro
→ Labor Day Warning: The secret that called 1929 is flashing something new (From Weiss Ratings) (Ad)tc pixel Free CGEM Stock Alerts

Cullinan Therapeutics (CGEM) Short Interest Ratio & Short Volume

Cullinan Therapeutics logo
$22.09 -0.07 (-0.32%)
As of 09/4/2026 04:00 PM Eastern
Compare

Cullinan Therapeutics Short Interest Overview

As of August 14, 2026, Cullinan Therapeutics (CGEM) had a short interest of 10.59 million shares sold short, representing 18.00% of the public float. This marks a 3.26% increase in short interest since the prior report. The short interest ratio (days to cover) is 15.5, meaning it would take 15.5 days of the average trading volume of 719,088 shares to cover all short positions.

Current Short Interest
10,588,430 shares
Previous Short Interest
10,254,541 shares
Change Vs. Previous Month
3.26%
Dollar Volume Sold Short
$215.37 million
Short Interest Ratio
15.5 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
64,360,000 shares
Short Percent of Float
18.00%
Today's Trading Volume
562,120 shares
Average Trading Volume
719,088 shares
Today's Volume Vs. Average
78%
Short Selling Cullinan Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Cullinan Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CGEM Short Interest Over Time

CGEM Days to Cover Over Time

CGEM Percentage of Float Shorted Over Time

Cullinan Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/202610,588,430 shares $215.37 million +3.3%18.0%15.45 $20.34
7/31/202610,254,541 shares $169.20 million -0.3%17.4%19.17 $16.50
7/15/202610,285,963 shares $183.40 million -2.9%18.3%15.22 $17.83
6/30/202610,597,500 shares $192.98 million +29.5%18.9%6.62 $18.21
6/15/20268,185,218 shares $111.40 million +2.7%14.6%6.29 $13.61
5/29/20267,973,648 shares $131.09 million -8.1%14.2%7.05 $16.44
5/15/20268,680,186 shares $136.54 million -1.4%15.5%8.19 $15.73
4/30/20268,799,071 shares $114.83 million +8.4%15.7%15.27 $13.05
4/15/20268,114,946 shares $121.32 million -3.3%14.4%10.56 $14.95
3/31/20268,394,357 shares $119.28 million +0.4%14.9%9.32 $14.21
3/13/20268,364,143 shares $112.83 million +3.5%14.9%10.63 $13.49
2/27/20268,080,892 shares $125.25 million +0.8%14.4%8.96 $15.50
2/13/20268,015,222 shares $92.90 million +0.5%14.3%11.67 $11.59
1/30/20267,976,684 shares $95.40 million -5.3%14.2%12 $11.96
1/15/20268,421,475 shares $89.77 million +3.5%15.0%12.18 $10.66
12/31/20258,136,316 shares $84.21 million +19.3%14.5%7.73 $10.35
12/15/20256,821,318 shares $73.81 million -0.8%12.1%5.34 $10.82
11/28/20256,876,864 shares $78.19 million +3.0%12.2%4.09 $11.37
11/14/20256,678,836 shares $57.10 million +2.6%12.0%9.63 $8.55
10/31/20256,509,523 shares $56.37 million -1.8%11.7%6 $8.66
10/15/20256,630,000 shares $57.22 million +8.7%18.0%8.1 $8.63
9/30/20256,100,000 shares $36.17 million -1.3%16.8%9.6 $5.93
9/15/20256,180,000 shares $39.24 million -1.0%17.0%14 $6.35
8/31/20256,240,000 shares $47.05 million +6.7%17.2%16.1 $7.54
8/15/20255,850,000 shares $44.81 million -9.3%16.1%16.6 $7.66
7/31/20256,450,000 shares $50.12 million +9.7%17.8%17.6 $7.77
7/15/20255,880,000 shares $43.81 million -1.8%16.4%15.6 $7.45
6/30/20255,990,000 shares $45.10 million +0.5%16.7%14.1 $7.53
6/15/20255,960,000 shares $51.32 million -3.6%16.6%13.9 $8.61
5/31/20256,180,000 shares $53.52 million +3.2%17.2%13.7 $8.66
5/15/20255,990,000 shares $43.37 million -19.9%16.7%13 $7.24
4/30/20257,480,000 shares $61.93 million -6.4%20.9%16.2 $8.28
4/15/20257,990,000 shares $62.32 million -6.3%22.5%17.3 $7.80
3/31/20258,530,000 shares $64.57 million -1.6%24.1%18.1 $7.57
3/15/20258,670,000 shares $76.21 million +0.1%24.4%17.7 $8.79
2/28/20258,660,000 shares $73.52 million -1.3%24.4%17.4 $8.49
2/15/20258,770,000 shares $83.58 million +0.5%24.6%17.2 $9.53
1/31/20258,730,000 shares $92.19 million -10.7%23.7%15.7 $10.56
1/15/20259,780,000 shares $99.56 million -0.4%26.6%18.4 $10.18
12/31/20249,820,000 shares $119.61 million +1.8%26.7%19 $12.18
How Long Does $2.5M Last in Retirement? (Ad)

Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors.tc pixel

Take the free quiz to get matched with a fiduciary advisor
12/15/20249,650,000 shares $113.39 million +5.4%26.0%19.5 $11.75
11/30/20249,160,000 shares $123.20 million +5.2%24.7%16.8 $13.45
11/15/20248,710,000 shares $120.72 million -3.4%23.5%16.2 $13.86
10/31/20249,020,000 shares $140.26 million -0.4%23.0%17.1 $15.55
10/15/20249,060,000 shares $147.13 million -1.6%23.2%15.7 $16.24
9/30/20249,210,000 shares $154.18 million +9.4%23.6%14.2 $16.74
9/15/20248,420,000 shares $151.14 million +4.6%21.6%11.7 $17.95
8/31/20248,050,000 shares $157.78 million -1.4%20.9%10.2 $19.60
8/15/20248,160,000 shares $137.99 million -2.4%21.2%10.3 $16.91
7/31/20248,360,000 shares $161.77 million +6.0%20.6%10 $19.35
7/15/20247,890,000 shares $130.90 million +0.6%19.4%8 $16.59
6/30/20247,840,000 shares $136.73 million +73.5%19.3%8 $17.44
6/15/20244,520,000 shares $85.34 million +4.2%10.3%5.1 $18.88
5/31/20244,340,000 shares $101.99 million +16.0%11.0%5.5 $23.50
5/15/20243,740,000 shares $99.93 million +58.5%11.9%5 $26.72
4/30/20242,360,000 shares $63.74 million +40.5%10.2%3.3 $27.01
4/15/20241,680,000 shares $27.80 million +16.7%6.4%3.1 $16.55
3/31/20241,440,000 shares $24.54 million +53.9%5.5%3.4 $17.04
3/15/2024935,400 shares $14.90 million +34.8%3.6%2.3 $15.93
2/29/2024694,100 shares $12.82 million -11.5%2.6%1.8 $18.47
2/15/2024783,900 shares $14.45 million -46.7%2.9%2.3 $18.43
1/31/20241,470,000 shares $22.26 million +34.9%5.4%5.1 $15.14
1/15/20241,090,000 shares $11.54 million +3.8%4.0%5.2 $10.59
12/31/20231,050,000 shares $10.70 million -48.5%3.9%5.4 $10.19
12/15/20232,040,000 shares $16.81 million -3.3%7.5%11.1 $8.24
11/30/20232,110,000 shares $17.28 million -2.3%7.8%12.5 $8.19
11/15/20232,160,000 shares $19.16 million +0.5%8.0%13.3 $8.87
10/31/20232,150,000 shares $20.06 million -1.8%7.9%12.9 $9.33
10/15/20232,190,000 shares $19.27 million -0.5%8.1%12.9 $8.80
9/30/20232,200,000 shares $19.91 million +0.9%8.1%12.1 $9.05
9/15/20232,180,000 shares $21.71 million -17.7%8.0%11.5 $9.96
8/31/20232,650,000 shares $27.43 million +33.2%9.8%10.2 $10.35
8/15/20231,990,000 shares $20.32 million +2.6%7.4%6.4 $10.21
7/31/20231,940,000 shares $20.54 million -18.5%8.2%6.1 $10.59
7/15/20232,380,000 shares $27.89 million +15.5%10.1%7.6 $11.72
6/30/20232,060,000 shares $22.17 million -11.6%8.7%6.8 $10.76
6/15/20232,330,000 shares $29.59 million +2.6%9.9%7.6 $12.70
5/31/20232,270,000 shares $23.34 million +0.9%9.6%8.6 $10.28
5/15/20232,250,000 shares $22.37 million +0.5%9.5%10.7 $9.94
4/30/20232,240,000 shares $21.80 million +0.5%9.5%10.7 $9.73
4/15/20232,230,000 shares $22.34 million +0.5%9.5%9.9 $10.02
3/31/20232,220,000 shares $22.71 million +1.8%9.4%10.2 $10.23
3/15/20232,180,000 shares $24.44 million +3.8%7.7%10.5 $11.21
2/28/20232,100,000 shares $23.71 million +1.5%7.0%13.3 $11.29
2/15/20232,070,000 shares $23.91 million +6.7%6.9%13.7 $11.55
1/31/20231,940,000 shares $22.58 million -9.4%6.6%13.7 $11.64
1/15/20232,140,000 shares $23.50 million -1.8%7.2%16.4 $10.98
12/30/20222,180,000 shares $23.00 million No Change7.4%17 $10.55
12/15/20222,180,000 shares $24.96 million No Change7.4%15.9 $11.45
11/30/20222,180,000 shares $27.10 million -5.6%7.4%14.8 $12.43
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad)

James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel

Watch James Altucher's free masterclass before September 25
11/15/20222,310,000 shares $29.48 million -4.9%8.0%14.2 $12.76
10/31/20222,430,000 shares $31.93 million -0.4%8.5%15.4 $13.14
10/15/20222,440,000 shares $30.79 million -1.2%8.5%15.7 $12.62
9/30/20222,470,000 shares $31.67 million +14.4%8.6%14.2 $12.82
9/15/20222,160,000 shares $28.21 million -13.6%7.5%10.9 $13.06
8/31/20222,500,000 shares $33.70 million No Change8.8%10.5 $13.48
8/15/20222,500,000 shares $35.40 million +2.9%8.8%8.5 $14.16
7/31/20222,430,000 shares $32.83 million -17.9%9.9%4.1 $13.51
7/15/20222,960,000 shares $43.57 million -1.7%12.1%4.9 $14.72
6/30/20223,010,000 shares $38.59 million -0.7%12.3%5.2 $12.82
6/15/20223,030,000 shares $36.09 million +6.3%12.4%5.2 $11.91
5/31/20222,850,000 shares $30.47 million +4.0%11.7%5.3 $10.69
5/15/20222,740,000 shares $29.10 million +3.8%11.2%5.7 $10.62
4/30/20222,640,000 shares $25.90 million +7.8%11.2%14.4 $9.81
4/15/20222,450,000 shares $27.44 million -3.5%10.4%13.2 $11.20
3/31/20222,540,000 shares $26.59 million -7.3%11.0%13.3 $10.47
3/15/20222,740,000 shares $34.91 million +1.5%12.1%13.2 $12.74
2/28/20222,700,000 shares $38.72 million +5.9%12.0%10.3 $14.34
2/15/20222,550,000 shares $37.69 million -3.4%11.3%9.6 $14.78
1/31/20222,640,000 shares $35.59 million -13.7%12.1%9.9 $13.48
1/15/20223,060,000 shares $41.89 million -1.0%13.4%11.4 $13.69
12/31/20213,090,000 shares $47.68 million +27.2%14.3%10.7 $15.43
12/15/20212,430,000 shares $38.71 million +3.4%11.2%9.4 $15.93
11/30/20212,350,000 shares $42.30 million -0.8%10.9%9.9 $18.00
11/15/20212,370,000 shares $49.68 million -7.8%8.1%9.3 $20.96
10/29/20212,570,000 shares $57.11 million +0.8%8.9%10.3 $22.22
10/15/20212,550,000 shares $63.75 million -1.9%8.8%10.6 $25.00
9/30/20212,600,000 shares $58.68 million +42.9%9.0%11.7 $22.57
9/15/20211,820,000 shares $52.78 million -24.5%6.3%7.6 $29.00

CGEM Short Interest - Frequently Asked Questions

Short interest is the volume of Cullinan Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 14th, investors have sold 10,588,430 shares of CGEM short. 18.00% of Cullinan Therapeutics' shares are currently sold short. Learn More on Cullinan Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEM shares currently have a short interest ratio of 15.5. Learn More on Cullinan Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.00% of Cullinan Therapeutics' floating shares are currently sold short.

Cullinan Therapeutics saw a increase in short interest in August. As of August 14th, there was short interest totaling 10,588,430 shares, an increase of 3.3% from the previous total of 10,254,541 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.00% of Cullinan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Cullinan Therapeutics: CRISPR Therapeutics AG (20.45%), Grifols, S.A. (0.52%), ACADIA Pharmaceuticals Inc. (7.45%), Dyne Therapeutics, Inc. (12.69%), Edgewise Therapeutics, Inc. (11.32%), Celcuity, Inc. (24.84%), Enliven Therapeutics, Inc. (11.62%), Relay Therapeutics, Inc. (19.87%), Legend Biotech Corporation Sponsored ADR (9.60%), Viking Therapeutics, Inc. (20.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling CGEM is an investing strategy that aims to generate trading profit from Cullinan Therapeutics as its price is falling. CGEM shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cullinan Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEM, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CGEM:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:CGEM is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
BlackRock and Vanguard already own THIS
Institutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...
Monument Traders Alliance | Sponsoredtc pixel
Musk just exposed the crack in his empire
SpaceX's IPO raised approximately $85.7 billion in gross proceeds. Days later, the company revealed its combin...
The Oxford Club | Sponsoredtc pixel
This looks like plywood. It's not.
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
This sub-5 dollar stock operates next to SpaceX and Blue Origin
A small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...
Freedom Financial | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Why the Treasury still prices gold at 42 dollars an ounce
The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...
Golden Portfolio | Sponsoredtc pixel